Aethlon Medical Inc (AEMD)

[bbarry]

AEMD mention in San Diego "Xconomy" News website

San Diego Biotechs Raise Cash for Novel Drugs to Treat Cancers, Broad Disease Spectrum
Bruce V. Bigelow 3/2/10
A number of biotechs and medical device companies in the San Diego area have disclosed funding deals in recent weeks. As I noted last month, San Diego-based ProActa raised about $1.1 million to continue its anti-cancer drug development work. I found some more deals while reviewing filings submitted to the Securities and Exchange Commission:

. . .

—Aethlon Medical (OTCBB: AEMD) has raised $600,000 from an unnamed investor, according to a recent SEC filing. The investor provided $300,000 in cash and a $300,000 loan to acquire 660,000 shares of Aethlon’s common stock. The San Diego-based company has been developing a blood purification device, the Hemopurifier, as a broad-spectrum therapy against infectious viral pathogens. In October, Aethlon formed a subsidiary, Exosome Sciences. The company says Exosome Sciences will run tests to see if the Hemopurifier also is effective in capturing exosomes that are secreted by solid tumors, lymphomas, and leukemias to suppress the patient’s immune response.
. . .
http://www.xconomy.com/san-diego/2010/03/02/san-diego-biotechs-raise-cash-for-novel-drugs-to-treat-cancers-broad-disease-spectrum/